In 2020, all but one of our most popular research briefings were, unsurprisingly, on the topic of COVID-19. And the articles in our most-read lists show just how rapidly our knowledge on the virus has grown over just a few months — from discoveries about characteristics of the virus itself, to the very first trial results on the Oxford/AstraZeneca ChAdOx1 COVID-19 vaccine in July.
It’s been an exciting year for scientific research, and one that’ll go down in the history books, with vaccines being developed in a matter of months, rather than years, and studies having an impact on clinical practice before they have even been published.
And The Pharmaceutical Journal has been dedicated to keeping up with, and reporting on, the most significant findings, in our research briefings and across all of our content types.
Here are your favourite research briefings from 2020:
9. Disproportionate impact of COVID-19 on BAME populations not explained by cardiometabolic factors, vitamin D or deprivation, researchers find
Still popular from 2019
- Enzyme mouth spray could shorten cold duration
- Potential interaction between diuretics and laxatives found
- Antidepressant treatment could assist weight loss
- Combination immunotherapy for melanoma improves long-term survival rates
- Oral spray delivers vitamin D as effectively as capsules, research suggests
Get in touch
Which topics would you like to see summarised in 2021? Send your ideas to email@example.com